PHARMACEUTICAL FORMULATION CONTAINING BOTULINUM NEUROTOXIN

摘要

FIELD: medicine.;SUBSTANCE: invention represents a pharmaceutical formulation possessing an ability to inhibit cardiac arrhythmias, containing the type A botulinum toxin and mucopolysaccharide specified in a group containing chitosan, heparin, nadroparin, hyaluronic acid taken in a ratio of 1:(103-109), preferentially 1:(106-108) by weight respectively with the ingredients of the formulation taken in certain relations.;EFFECT: higher pharmacological activity, reduced required single dose for achieving the required therapeutic effect, prolonging the action of botulinum toxin and reduced side effects botulinum toxin.;8 cl